ENO2 and cholangiocarcinoma: As shown in Figure 6A-B, in CCA cells, the HSP90 inhibitor significantly reversed the up-regulation of HIF1A protein expression caused by USP21 overexpression, and thus reversed the protein and mRNA expression levels of glycolytic enzyme genes ENO2, ENO3, ALDOC, and ACSS2.